The SNM is ratcheting up political pressure on Congress to restore $20 million in Department of Energy research funding that it considers crucial to the survival of nuclear medicine.
The SNM is ratcheting up political pressure on Congress to restore $20 million in Department of Energy research funding that it considers crucial to the survival of nuclear medicine.
The professional society placed a full-page, full-color ad in the Sept. 30 issue of Roll Call, a daily newspaper of Congressional news widely read by legislators and their staffs.
The ad features a group of scientists with turned backs, walking away. The headline says, "Say goodbye to the next Einstein, Salk or Madame Curie," in a reference to world-class scientists that the SNM leaders fear will not pursue basic discoveries relevant to nuclear medicine because of diminished DOE involvement.
The ad makes the following appeal: "Congress: Don't turn your back on future discoveries. Support DOE funding for nuclear medicine research."
The SNM has lobbied for the restoration of funding since the Bush administration cut $23 million from the 2006 federal budget for basic research at the DOE. The cuts signaled to many nuclear medicine researchers an end to DOE's 50-year involvement in nuclear medicine science.
Congress first began funding nuclear medicine research with the passage of the Atomic Energy Act of 1954. DOE laboratories and researchers are widely credited with many discoveries and innovations that laid the basis for clinical nuclear medicine practice. They helped develop imaging instrumention, such as SPECT and PET, and discover and develop clinical applications for technetium-99m and fluorine-18 FDG, the mainstay isotopes and radiopharmaceuticals used in routine clinical practice.
There has been some recent movement on Capitol Hill to restore funding. The Senate Energy and Water Appropriation Committee raised the DOE budget for medical applications and medical science by $20 million, specifically for nuclear medicine research. The committee also noted its disappointment in the DOE for eliminating funding for nuclear medicine research for each of the past three years.
The issue was not addressed in the budget passed by the House Appropriations subcommittee on energy and water development, according to Mike Peters, a healthcare policy analyst with the SNM. However, subcommittee chair Peter Visclosky (D-IN) and Appropriations Committee chair David Obey (D-WI) have signed a letter addressed to House colleagues supporting funding restoration.
The issue may be ultimately addressed in joint House-Senate budget reconciliation talks later this year.
The SNM has accelerated efforts to restore the fund since publication in September of a National Academy of Sciences report on the state of nuclear medicine science. It stressed the importance of the DOE laboratories for the recruitment and training of nuclear physicists and chemists deemed crucial to carrying on the work of scientists who are retiring from the field.
The NAS report called for enhanced federal commitment to nuclear medicine research and recommended that DOE and the National Institutes of Health convene expert panels to identify critical national needs for training nuclear medicine scientists.
"This report confirms that funding for this nation's basic research program must be restored, or future live-saving diagnostic and treatment procedures could be lost to all Americans," said SNM president Dr. Alexander J. McEwan in a release.
For more information from the Diagnostic Imaging archives:
NAS report recommends renewed federal leadership in nuclear medicine science
Nuclear medicine experts dominate national panel
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
July 15th 2024Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.